Search

Author/Creator Chernyak, Nadja

1. Clinical efficacy and safety outcomes of bempedoic acid for LDL-C lowering therapy in patients at high cardiovascular risk: a systematic review and meta-analysis. Issue 2 (24th February 2022)

Authors:
Lin, Yingfeng; Parco, Claudio; Karathanos, Athanasios; Krieger, Torben; Schulze, Volker; Chernyak, Nadja; Icks, Andrea; Kelm, Malte; Brockmeyer, Maximilian; Wolff, Georg
Journal:
BMJ open
Issue:
Volume 12:Issue 2(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease. Issue 2 (30th November 2022)

Authors:
Brockmeyer, Maximilian; Wies, Emilia; Joerges, Jamuna; Sommer, Jana; Borgmann, Sandra Olivia; Chernyak, Nadja; Lin, Yingfeng; Parco, Claudio; Schulze, Volker; Heinen, Yvonne; Kelm, Malte; Icks, Andrea; Perings, Stefan; Wolff, Georg
Journal:
Clinical cardiology
Issue:
Volume 46:Issue 2(2023)
Page Start:
223
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗